Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2015 Financial Results on May 12, 2015

WOODCLIFF LAKE, N.J.--()--Eagle Pharmaceuticals, Inc. ("Eagle") (Nasdaq:EGRX) announced today that the Company will release its 2015 first quarter financial results on Tuesday, May 12, 2015, before the market opens.

Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date       Tuesday, May 12, 2015  
Time 8:30 A.M. EDT
Toll free (U.S.) 877-876-9176
International 785-424-1667
Webcast (live and replay)

www.eagleus.com. under the “Investor Relations” section

 

A replay of the conference call will be available for one week after the call's completion by dialing 800-374-0328 (US) or 402-220-0663 (International) and entering conference call ID EGRXQ114. The webcast will be archived for 30 days at the aforementioned URL.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway.   Additional information is available on the company’s website at www.eagleus.com.

Contacts

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Recent Stories

RSS feed for Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.